RantCrush Top 5: September 7, 2016

After working hard to generate a virtual monopoly on the EpiPen market, Mylan moved to raise its prices by nearly 30 percent. The company has so far deflected any insinuations of prices gouging, but billions in profits over the past two years since the price increase began tell a different story. Heather Bresch, Mylan’s CEO, saw her salary increased by 600 percent in the same year. Hmm, what a strange coincidence!

Senator Bernie Sanders argued that moves such as this demonstrate “that the company values profits more than the lives of millions of Americans.” In response to this alleged money grab and the outrage it caused, Mylan is taking advantage of PR damage control by touting its freebie programs and its donations to schools.

However, lawmakers have not been fooled, New York’s Attorney General recently launched a probe into anti-trust activity and the FTC is considering its own investigation. Time will tell, but after Shkreli-gate, American trust in pharmaceutical honesty is flagging.

via GIPHY

Rant Crush

RantCrush collects the top trending topics in the law and policy world each day just for you.